Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.

× No keyword cloud information.

16 in total

1. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.

Authors: M A Westerink; A A Campagnari; M A Wirth; M A Apicella
Journal: Infect Immun Date: 1988-05 Impact factor: 3.441

2. Editorial: Vaccination against meningitis.

Authors:
Journal: Br Med J Date: 1976-04-17

3. Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines.

Authors: J M Griffiss; B L Brandt; D D Broud
Journal: Infect Immun Date: 1982-07 Impact factor: 3.441

4. Immunogenicity of polysaccharides from type III, group B Streptococcus.

Authors: C J Baker; M S Edwards; D L Kasper
Journal: J Clin Invest Date: 1978-04 Impact factor: 14.808

5. Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody.

Authors: M S Artenstein
Journal: Bull World Health Organ Date: 1971 Impact factor: 9.408

6. Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.

Authors: Maheshi N Ramasamy; Elizabeth A Clutterbuck; Kathryn Haworth; Jaclyn Bowman; Omar Omar; Amber J Thompson; Geraldine Blanchard-Rohner; Ly-Mee Yu; Matthew D Snape; Andrew J Pollard
Journal: Clin Vaccine Immunol Date: 2014-06-25

Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.

1. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.

2. Editorial: Vaccination against meningitis.

3. Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines.

4. Immunogenicity of polysaccharides from type III, group B Streptococcus.

5. Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody.

6. Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.

7. Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.

8. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.

9. Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

10. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.